Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

MTOR/STAT3 signal inhibitor-treated mesenchymal stem cell having immunomodulatory activity, and cell therapy composition comprising same, for preventing or treating immune disorders

US Patent 10851346 · Granted Dec 1, 2020

Assignee

Inventors

View full patent text on Google Patents →